Search Results - "Tahamtan, Ouria"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial by Sadeghipour, Parham, Talasaz, Azita H, Rashidi, Farid, Sharif-Kashani, Babak, Beigmohammadi, Mohammad Taghi, Farrokhpour, Mohsen, Sezavar, Seyed Hashem, Payandemehr, Pooya, Dabbagh, Ali, Moghadam, Keivan Gohari, Jamalkhani, Sepehr, Khalili, Hossein, Yadollahzadeh, Mahdi, Riahi, Taghi, Rezaeifar, Parisa, Tahamtan, Ouria, Matin, Samira, Abedini, Atefeh, Lookzadeh, Somayeh, Rahmani, Hamid, Zoghi, Elnaz, Mohammadi, Keyhan, Sadeghipour, Pardis, Abri, Homa, Tabrizi, Sanaz, Mousavian, Seyed Masoud, Shahmirzaei, Shaghayegh, Bakhshandeh, Hooman, Amin, Ahmad, Rafiee, Farnaz, Baghizadeh, Elahe, Mohebbi, Bahram, Parhizgar, Seyed Ehsan, Aliannejad, Rasoul, Eslami, Vahid, Kashefizadeh, Alireza, Kakavand, Hessam, Hosseini, Seyed Hossein, Shafaghi, Shadi, Ghazi, Samrand Fattah, Najafi, Atabak, Jimenez, David, Gupta, Aakriti, Madhavan, Mahesh V, Sethi, Sanjum S, Parikh, Sahil A, Monreal, Manuel, Hadavand, Naser, Hajighasemi, Alireza, Maleki, Majid, Sadeghian, Saeed, Piazza, Gregory, Kirtane, Ajay J, Van Tassell, Benjamin W, Dobesh, Paul P, Stone, Gregg W, Lip, Gregory Y. H, Krumholz, Harlan M, Goldhaber, Samuel Z, Bikdeli, Behnood

    “…IMPORTANCE: Thrombotic events are commonly reported in critically ill patients with COVID-19. Limited data exist to guide the intensity of antithrombotic…”
    Get full text
    Journal Article
  2. 2

    Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial

    Published in BMJ (Online) (07-01-2022)
    “…To assess the effect of statin treatment versus placebo on clinical outcomes in patients with covid-19 admitted to the intensive care unit (ICU)…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial by Bikdeli, Behnood, Talasaz, Azita H, Rashidi, Farid, Bakhshandeh, Hooman, Rafiee, Farnaz, Rezaeifar, Parisa, Baghizadeh, Elahe, Matin, Samira, Jamalkhani, Sepehr, Tahamtan, Ouria, Sharif-Kashani, Babak, Beigmohammadi, Mohammad Taghi, Farrokhpour, Mohsen, Sezavar, Seyed Hashem, Payandemehr, Pooya, Dabbagh, Ali, Moghadam, Keivan Gohari, Khalili, Hossein, Yadollahzadeh, Mahdi, Riahi, Taghi, Abedini, Atefeh, Lookzadeh, Somayeh, Rahmani, Hamid, Zoghi, Elnaz, Mohammadi, Keyhan, Sadeghipour, Pardis, Abri, Homa, Tabrizi, Sanaz, Mousavian, Seyed Masoud, Shahmirzaei, Shaghayegh, Amin, Ahmad, Mohebbi, Bahram, Parhizgar, Seyed Ehsan, Aliannejad, Rasoul, Eslami, Vahid, Kashefizadeh, Alireza, Dobesh, Paul P, Kakavand, Hessam, Hosseini, Seyed Hossein, Shafaghi, Shadi, Ghazi, Samrand Fattah, Najafi, Atabak, Jimenez, David, Gupta, Aakriti, Madhavan, Mahesh V, Sethi, Sanjum S, Parikh, Sahil A, Monreal, Manuel, Hadavand, Naser, Hajighasemi, Alireza, Maleki, Majid, Sadeghian, Saeed, Piazza, Gregory, Kirtane, Ajay J, Van Tassell, Benjamin W, Stone, Gregg W, Lip, Gregory Y H, Krumholz, Harlan M, Goldhaber, Samuel Z, Sadeghipour, Parham

    Published in Thrombosis and haemostasis (01-01-2022)
    “…Thrombotic complications are considered among the main extrapulmonary manifestations of coronavirus disease 2019 (COVID-19). The optimal type and duration of…”
    Get more information
    Journal Article
  5. 5
  6. 6
  7. 7